These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33762918)

  • 1. Transcutaneous Auricular Neurostimulation (tAN): A Novel Adjuvant Treatment in Neonatal Opioid Withdrawal Syndrome.
    Jenkins DD; Khodaparast N; O'Leary GH; Washburn SN; Covalin A; Badran BW
    Front Hum Neurosci; 2021; 15():648556. PubMed ID: 33762918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivering transcutaneous auricular neurostimulation (tAN) to improve symptoms associated with opioid withdrawal: results from a prospective clinical trial.
    Tirado CF; Washburn SN; Covalin A; Hedenberg C; Vanderpool H; Benner C; Powell DP; McWade MA; Khodaparast N
    Bioelectron Med; 2022 Aug; 8(1):12. PubMed ID: 35978394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
    McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
    J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pragmatic, randomized, blinded trial to shorten pharmacologic treatment of newborns with neonatal opioid withdrawal syndrome (NOWS).
    Czynski A; Laptook A; Das A; Smith B; Simon A; Greenberg R; Annett R; Lee J; Snowden J; Pedroza C; Lester B; Eggleston B; Bremer D; McGowan E
    Trials; 2023 Jul; 24(1):466. PubMed ID: 37480087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin as Adjunctive Therapy in Neonatal Opioid Withdrawal Syndrome: A Case Series.
    Patz C; Liviskie C; Bird M; Zeller B; Vesoulis ZA; Smyser CD; McPherson C
    J Pediatr Pharmacol Ther; 2023; 28(4):368-373. PubMed ID: 37795276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid withdrawal behavior in spiny mice: A novel preclinical model of neonatal opioid withdrawal syndrome (NOWS).
    Stevens S; Mohan S
    Heliyon; 2021 Apr; 7(4):e06694. PubMed ID: 33898824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome.
    Merhar SL; Ounpraseuth S; Devlin LA; Poindexter BB; Young LW; Berkey SD; Crowley M; Czynski AJ; Kiefer AS; Whalen BL; Das A; Fuller JF; Higgins RD; Thombre V; Lester BM; Smith PB; Newman S; Sánchez PJ; Smith MC; Simon AE;
    Pediatrics; 2021 Mar; 147(3):. PubMed ID: 33632932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Associated With the Need for Pharmacological Management of Neonatal Opioid Withdrawal Syndrome.
    Scott LF; Guilfoy V; Duwve JM; Rawl SM
    Adv Neonatal Care; 2020 Oct; 20(5):364-373. PubMed ID: 32868586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avoiding NICU Transfers for Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS): A Quality Improvement Initiative to Manage NOWS on the Mother-baby Unit.
    Spence K; Boedeker R; Harhausen M; Kaushal G; Buchanan P; Josephsen J
    J Addict Med; 2020; 14(5):401-408. PubMed ID: 31972766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical care of neonates undergoing opioid withdrawal in the immediate postpartum period.
    Oji-Mmuo CN; Jones AN; Wu EY; Speer RR; Palmer T
    Neurotoxicol Teratol; 2021; 86():106978. PubMed ID: 33838247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and iatrogenic neonatal opioid withdrawal syndrome: Differences and similarities in recognition, management, and consequences.
    Isaac L; van den Hoogen NJ; Habib S; Trang T
    J Neurosci Res; 2022 Jan; 100(1):373-395. PubMed ID: 33675100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of auricular acupressure as an adjunct treatment for neonatal opioid withdrawal syndrome (NOWS).
    Jackson HJ; Lopez C; Miller S; Englehardt B
    Subst Abus; 2021; 42(3):348-357. PubMed ID: 32635829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental DNA methylation profiles in opioid-exposed pregnancies and associations with the neonatal opioid withdrawal syndrome.
    Radhakrishna U; Vishweswaraiah S; Uppala LV; Szymanska M; Macknis J; Kumar S; Saleem-Rasheed F; Aydas B; Forray A; Muvvala SB; Mishra NK; Guda C; Carey DJ; Metpally RP; Crist RC; Berrettini WH; Bahado-Singh RO
    Genomics; 2021 May; 113(3):1127-1135. PubMed ID: 33711455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiorespiratory anomalies and increased brainstem microglia in a rat model of neonatal opioid withdrawal syndrome.
    Osborne A; Mayer CA; Hoffman A; Cali V; Hyzny R; Lewis SJ; MacFarlane PM
    Respir Physiol Neurobiol; 2022 Feb; 296():103800. PubMed ID: 34626831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole body massage for newborns: A report on non-invasive methodology for neonatal opioid withdrawal syndrome.
    Rana D; Garde K; Elabiad MT; Pourcyrous M
    J Neonatal Perinatal Med; 2022; 15(3):559-565. PubMed ID: 35599503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental microRNA methylome signatures may serve as biomarkers and therapeutic targets for prenatally opioid-exposed infants with neonatal opioid withdrawal syndrome.
    Radhakrishna U; Nath SK; Uppala LV; Veerappa A; Forray A; Muvvala SB; Metpally RP; Crist RC; Berrettini WH; Mausi LM; Vishweswaraiah S; Bahado-Singh RO
    Front Genet; 2023; 14():1215472. PubMed ID: 37434949
    [No Abstract]   [Full Text] [Related]  

  • 17. Placental
    Wachman EM; Wang A; Isley BC; Boateng J; Beierle JA; Hansbury A; Shrestha H; Bryant C; Zhang H
    Explor Med; 2020 Jun; 1(3):124-135. PubMed ID: 33763662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine vs. morphine: impact on neonatal opioid withdrawal syndrome (NOWS) outcomes in a single center retrospective study.
    Anbalagan S; Anderson V; Favara MT; Stark D; Carola D; Solarin K; Adeniyi-Jones S; Kraft WK; Aghai ZH
    J Perinatol; 2024 Jul; ():. PubMed ID: 39003405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome.
    Chavan NR; Ashford KB; Wiggins AT; Lofwall MR; Critchfield AS
    AJP Rep; 2017 Oct; 7(4):e215-e222. PubMed ID: 29226017
    [No Abstract]   [Full Text] [Related]  

  • 20. The Time is NOW: Filling the Gaps in Treatment of Opioid-Exposed Infants: A Prospective, Pragmatic, Randomized Control Drug Trial.
    Czynski AJ; Laptook AR
    R I Med J (2013); 2021 Apr; 104(3):17-21. PubMed ID: 33789403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.